IXICOLSE:IXI PB Ratio is 0.73 as of Jun. 25, 2026, which is 59% below its 10-year median of 1.77. The stock has 2 warning signs investors should review. Among 1,233 Biotechnology companies, IXICO ranks better than 90.27% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), IXICO's share price is £0.0845. IXICO's Book Value per Share for the quarter that ended in Mar. 2026 was £0.12. Hence, IXICO's PB Ratio of today is 0.73.
The historical rank and industry rank for IXICO's PB Ratio or its related term are showing as below:
LSE:IXI'
s PB Ratio Range Over the Past 10 Years
Min: 0.29 Med: 1.77 Max: 5.88
Current: 0.73
During the past 13 years, IXICO's highest PB Ratio was 5.88. The lowest was 0.29. And the median was 1.77.
LSE:IXI's PB Ratio is ranked better than 90.27% of 1233
companies
in the Biotechnology industry
Industry Median: 2.83
vs LSE:IXI: 0.73
During the past 12 months, IXICO's average Book Value Per Share Growth Rate was -12.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -21.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -8.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of IXICO was 62.60% per year. The lowest was -57.20% per year. And the median was -5.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
IXICO PB Ratio Related Terms
IXICO PB Ratio Historical Data
* Premium members only.
The historical data trend for IXICO's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, IXICO's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IXICO PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IXICO's PB Ratio distribution charts can be found below:
* The bar in red indicates where IXICO's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
IXICO's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
IXICO (LSE:IXI) has a PB Ratio of 0.73 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on IXICO and its competitors. This is 59% below median its historical median of 1.77. Over the past decade, IXICO's PB Ratio has ranged from 0.29 to 5.88. According to the industry distribution chart, IXICO ranks #120 out of 1233 companies in the Biotechnology industry, placing it in the top 9.7%.
Is IXICO's PB Ratio too high?
IXICO's current PB Ratio of 0.73 is 59% below median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 5.88. The Biotechnology industry median PB Ratio is 2.83. IXICO's value of 0.73 is 74.2% below this industry median. Based on the distribution chart, IXICO ranks #120 out of 1233 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does IXICO's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, IXICO ranks #120 out of 1233 companies for PB Ratio. This places IXICO in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.83. IXICO's value of 0.73 is 74.2% below this benchmark. Historically, IXICO's own PB Ratio has ranged from 0.29 to 5.88 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 2.83, IXICO has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.83, based on 1,233 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IXICO's current PB Ratio of 0.73 is 74.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on IXICO and its competitors. For the Biotechnology industry, the median PB Ratio is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IXICO's current PB Ratio is 0.73, which is 59% below median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Fairly Valued. The stock's GF Value™ is £0.08, compared to a current price of £0.08 — trading 5.6% above its estimated fair value. The current PB Ratio is 0.73, which is 59% below median its 10-year median of 1.77 and 74.2% below the Biotechnology industry median of 2.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For IXICO (LSE:IXI), the current PB Ratio is 0.73 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IXI has been successfully added to your 